上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性，接下來我們將會繼續深入探討問題。1331Please respect copyright.ＰＥＮＡＮＡgctBiBebYC
1331Please respect copyright.ＰＥＮＡＮＡl6oWDBqomu
上集：https://www.penana.com/article/4711251331Please respect copyright.ＰＥＮＡＮＡZ1JVLHwYP2
1331Please respect copyright.ＰＥＮＡＮＡsTTwa6Umfw
1331Please respect copyright.ＰＥＮＡＮＡAnTd7TeXXv
1331Please respect copyright.ＰＥＮＡＮＡiy6ezPLSmq
（圖1）雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力，但另一個重要的問題是，如何確保有足夠的T cell殺滅癌細胞呢?1331Please respect copyright.ＰＥＮＡＮＡG09s0Pr4uw
1331Please respect copyright.ＰＥＮＡＮＡkBfbgqLirR
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物，但免疫系統細胞數量不足的話，依然是不會達到重大效果的。1331Please respect copyright.ＰＥＮＡＮＡwJOhA7W9XS
1331Please respect copyright.ＰＥＮＡＮＡKiEbuWrEOm
換句話說，我們需要一道能夠提升針對癌細胞的T cell數量手段。1331Please respect copyright.ＰＥＮＡＮＡIhFqlqscy9
1331Please respect copyright.ＰＥＮＡＮＡhIBx9B8LTW
1331Please respect copyright.ＰＥＮＡＮＡPFphkXZJia
1331Please respect copyright.ＰＥＮＡＮＡ2YnwepzEXu
（圖2）T cell的產生數量，接近可以說是由Antigen Presenting Cells(APC)來決定;1331Please respect copyright.ＰＥＮＡＮＡLmw5pFQcsl
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1331Please respect copyright.ＰＥＮＡＮＡtuA9PAMQV6
1331Please respect copyright.ＰＥＮＡＮＡBI44j1991R
忘記甚麼是Neoantigen的話，可重溫上一集。1331Please respect copyright.ＰＥＮＡＮＡTpGSt3GR2T
1331Please respect copyright.ＰＥＮＡＮＡWLTQzm2dzj
當APC展示癌細胞的Neoantigen予T cell的receptor後，另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1331Please respect copyright.ＰＥＮＡＮＡRwmlX1glRq
1331Please respect copyright.ＰＥＮＡＮＡsCWPab8Jcz
只要兩者條件達成的話，負責對付對應癌細胞的T cell數量及效力便會大增。1331Please respect copyright.ＰＥＮＡＮＡFqhEKW2iLi
1331Please respect copyright.ＰＥＮＡＮＡljeULBdzsP
1331Please respect copyright.ＰＥＮＡＮＡUo1ptVdFJa
1331Please respect copyright.ＰＥＮＡＮＡjuF5CQkrFB
（圖3）然而，當T cell數量產生至一定程度的時候，T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置，與B7合併。1331Please respect copyright.ＰＥＮＡＮＡ8B6FMKQwJF
1331Please respect copyright.ＰＥＮＡＮＡ7IQ6ap5Su4
而當CTLA4與B7合併後，T cell所產生的數量及威力就會大減。1331Please respect copyright.ＰＥＮＡＮＡljcRJlWM64
1331Please respect copyright.ＰＥＮＡＮＡh2Qqc9aE2Y
這個CTLA4產生的機制是與生俱來的，目的就是為了避免產生過量的T cell，以免身體會產生不良反應。1331Please respect copyright.ＰＥＮＡＮＡLWhCtNcCH1
1331Please respect copyright.ＰＥＮＡＮＡgPmMFqWkvE
1331Please respect copyright.ＰＥＮＡＮＡhjmVLx9DxJ
（圖4）只不過的是，現時癌細胞大敵當前，燃眉之急就是要調動大量的T cell前往討伐癌細胞。1331Please respect copyright.ＰＥＮＡＮＡGKJIoTUsK9
1331Please respect copyright.ＰＥＮＡＮＡiYC0Z5GX1c
為此，我們重施應對PD1/PDL1故技，利用抗體阻擋CTLA4，確保CD28及B7持續合併，不斷產生效力高強的T cell。1331Please respect copyright.ＰＥＮＡＮＡtcjXcObtNn
1331Please respect copyright.ＰＥＮＡＮＡ5rb1Qe0vVW
1331Please respect copyright.ＰＥＮＡＮＡ89NOJzpii3
（圖5）簡略的總結來說，為了確保有足夠的T cell消滅癌細胞，我們不惜採用阻擋CTLA4的抗體，號令身體持續產生效力高強的T cell。1331Please respect copyright.ＰＥＮＡＮＡiK7ps723fG
而另一邊廂，我們亦同時利用阻擋PD1/PDL1的抗體，確保T cell能夠順利把癌細胞辨認成為外來物，將其制裁。1331Please respect copyright.ＰＥＮＡＮＡXzOeEDfXkD
1331Please respect copyright.ＰＥＮＡＮＡetKBjzrp4x
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法，將能大大提升免疫治療的效率。1331Please respect copyright.ＰＥＮＡＮＡDJOXmHViOB
1331Please respect copyright.ＰＥＮＡＮＡIEkxQ0CrOa
但是，並不是所有病人也能依靠這方法而得益，原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1331Please respect copyright.ＰＥＮＡＮＡ32ZlCWVV6U
1331Please respect copyright.ＰＥＮＡＮＡ6dEjXGAO5F
這一方面，我們將會在下一篇免疫治療的最終章再作探討。1331Please respect copyright.ＰＥＮＡＮＡvSbwnwRqNF
1331Please respect copyright.ＰＥＮＡＮＡa356Ty84ye
1331Please respect copyright.ＰＥＮＡＮＡf2lBAaQ1vp
如果想我快啲出文的話，請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark，這對我非常之重要。1331Please respect copyright.ＰＥＮＡＮＡr1mjhjFjCt
1331Please respect copyright.ＰＥＮＡＮＡrNAa00OYUT
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1331Please respect copyright.ＰＥＮＡＮＡfzsfxsYNpN
1331Please respect copyright.ＰＥＮＡＮＡr2sh2Dy1AU
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」，以課金的方式推動我繼續搜羅資料寫文，多謝。1331Please respect copyright.ＰＥＮＡＮＡ38r0tnn3nQ
1331Please respect copyright.ＰＥＮＡＮＡZpAD4QaRJR
Link:1331Please respect copyright.ＰＥＮＡＮＡ3k2FjbeM3t
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1331Please respect copyright.ＰＥＮＡＮＡNVARXL85rI
1331Please respect copyright.ＰＥＮＡＮＡKUoCuEWaK4
1331Please respect copyright.ＰＥＮＡＮＡ4rz1qiRm2l
有興趣接收科普資訊的話，歡迎follow IG: potatopigtongue。1331Please respect copyright.ＰＥＮＡＮＡEuSj24FB86
8964 copyright protection1327ＰＥＮＡＮＡMMn3hFyUMZ 維尼

3.144.10.140